Effector and memory T-cell differentiation: implications for vaccine development
The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Abstract
Recent work shows that after stimulation with antigen, CD4+ and CD8+ T cells embark on a programme of proliferation that is closely linked with the acquisition of effector functions and leads ultimately to memory-cell formation. Here, we discuss the signals required for commitment to this programme of development and the factors that might influence its progression. Models of the pathways of effector and memory T-cell differentiation are discussed, and we highlight the implications of this new understanding for the optimization of vaccine strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The relatively few naïve T-cells during early reconstitution is consistent with programmed recovery in patients following chemotherapy [39, 40], immune checkpoint blockade [20, 24], or after infection [41, 42].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [41]
In the citing paper
“These kinetics are consistent with a typical T cell response after the effector phase (53).”
From mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern (2021) · cites this paper as [53]
In the citing paper
“the central memory (CM) or effector memory (EM) differentiation states of CD4+ and CD8+ T cells have implications for durability, recirculation, tissue access, and responses upon antigen re-exposure (Kaech et al., 2002; Martin and Badovinac, 2018; Wherry et al., 2003).”
From Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination (2021) · cites this paper as Kaech et al., 2002
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationPreferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Self-citationImmunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Stages of T-cell responses The path towards memory T-cell development continues to be delineated, but there are clearly three stages that T cells pass through as they differentiate into memory cell”
Self-citationOut of Eden: Stem Cells and Their Niches
Watt, F. M., & Hogan, A. B. L. M. (2000) · Science · doi:10.1126/science.287.5457.1427 · Cited by 1,758
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Research works printed but not linked: 1
- Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131–2142 (1998). · doi:10.1002/(sici)1521-4141(199807)28:07<2131::aid-immu2131>3.0.co;2-q
Cited by
Items 601–700 of 1,003
Tan, G. S., McKenna, P. M., Koser, M. L., McLinden, R., Kim, J. H., McGettigan, J. P., & Schnell, M. J. (2004) · Virology · doi:10.1016/j.virol.2004.10.018 · Cited by 44
“, 2002, 2003), others indicate that strong cellular responses will also be necessary for an effective HIV-1 vaccine (Kaech et al., 2002; Seder and Hill, 2000; Yang, 2003).”
Committed to memory: lineage choices for activated T cells
Moulton, V. R., & Färber, D. L. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.006 · Cited by 44
Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection
Opata, M. M., & Stephens, R. (2014) · Current Immunology Reviews · doi:10.2174/1573395509666131126231209 · Cited by 51
Benson, R. A., Adamson, K., Corsin-Jimenez, M., Marley, J. V., Wahl, K. A., Lamb, J. R., & Howie, S. (2005) · European Journal of Immunology · doi:10.1002/eji.200425562 · Cited by 44
Sieg, S. F., Rodriguez, B. A., Asaad, R. J., Jiang, W., Bazdar, D. A., & Lederman, M. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/430620 · Cited by 44
Protective and Memory Immunity to Histoplasma capsulatum in the Absence of IL-10
Deepe, G. S., & Gibbons, R. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5353 · Cited by 46
Lefrançois, L., Marzo, A. L., & Williams, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2832 · Cited by 44
“Conversely, central memory cells may be derived from activated cells that do not traverse an effector phase (3, 12).”
BackgroundLamin A/C and the Immune System: One Intermediate Filament, Many Faces
Saéz, Á., Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., Rius, C., & González, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176109 · Cited by 45
“[193] T cell activation is triggered by the recognition of an antigen presented by APCs in the context of MHCII for CD4+ T cells or MHCI for CD8+ T cells [186,187].”
InfluentialmiRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease
Dhuppar, S., & Murugaiyan, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.09.003 · Cited by 47
Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications
Oseghale, O., Vlahos, R., O’Leary, J. J., Brooks, R. D., Brooks, D. A., Liong, S., & Selemidis, S. (2022) · Viruses · doi:10.3390/v14122729 · Cited by 47
“Autopsy reports suggested that the onset of pulmonary oedema created an environment conducive for secondary bacterial pneumonia development, which potentially explains the subsequent increases in mortality [67,68].”
Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection
Reynolds, T. D., Buonocore, L., Rose, N. F., Rose, J. K., & Robek, M. D. (2015) · Journal of Virology · doi:10.1128/jvi.01184-15 · Cited by 43
“Indeed, it is unknown how long antigen persists after VLV inoculation, a factor that can influence memory T cell development (28).”
BackgroundZhang, W., Wang, L., Liu, Y., Chen, X., Li, J., Yang, T., An, W., Ma, X., Pan, R., & Ma, G. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1224-z · Cited by 44
Chapuis, A. G., Casper, C., Kuntz, S., Zhu, J., Tjernlund, A., Diem, K., Turtle, C. J., Cigal, M., Velez, R., Riddell, S. R., et al. (2011) · Blood · doi:10.1182/blood-2010-11-320226 · Cited by 43
Notch system in the linkage of innate and adaptive immunity
Ito, T., Connett, J. M., Kunkel, S. L., & Matsukawa, A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1011529 · Cited by 45
Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension
Veeranki, S., Gandhapudi, S. K., & Tyagi, S. C. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0568 · Cited by 45
Wei, J., Xue, W., Yu, X., Qiu, X., & Liu, Z. (2017) · Journal of Biomaterials Applications · doi:10.1177/0885328217704139 · Cited by 43
Effector lymphoid tissue and its crucial role in protective immunity
van Panhuys, N., Perret, R., PROUT, M., Ronchese, F., & Gros, G. S. L. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.03.005 · Cited by 42
T‐lymphocyte subset distribution in human spleen
Langeveld, M., Gamadia, L. E., & ten Berge, I. J. M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01626.x · Cited by 43
HIV-1 transgenic rats develop T cell abnormalities
Reid, W. C., Abdelwahab, S. F., Sadowska, M., Huso, D. L., Neal, A. E., Ahearn, A., Bryant, J., Gallo, R. C., Lewis, G. K., & Reitz, M. S. (2004) · Virology · doi:10.1016/j.virol.2003.12.010 · Cited by 46
“It has been previously reported that effector/ memory T cell populations are maintained by homeostatic proliferation, which depends upon the cytokine microenvironment (Kaech et al., 2002; Murali-Krishna et al., 1998; Seddon and Zamoyska, 2003; Seddon et al., 2003).”
Cutting Edge: IL-15–Independent Maintenance of Mucosally Generated Memory CD8 T Cells
Verbist, K., Field, M. B., & Klonowski, K. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004022 · Cited by 43
“The current model of Tmem development dictates that after pathogen clearance a small proportion of effector CD8 T cells (Teff) survive and emerge as a stable Tmem pool that is maintained in the absence of Ag via sustained cytokine signaling (1).”
BackgroundJunqueira‐Kipnis, A. P., Turner, J., Juarrero, M. G., Turner, O. C., & Orme, I. M. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.570-575.2004 · Cited by 43
Zhang, J., Jiao, D., Qi, X., Zhang, Y., Liu, X., Pan, T., Gao, H., Liu, Z., Ding, D., & Feng, G. (2025) · Advanced Science · doi:10.1002/advs.202410405 · Cited by 54
The effector to memory transition of CD4 T cells
McKinstry, K. K., Strutt, T. M., & Swain, S. L. (2007) · Immunologic Research · doi:10.1007/s12026-007-8004-y · Cited by 50
“That a unique subset of ‘pre-memory’ effectors gives rise to long-lived CD4 T cells, or that memory cells result from the stochastic survival of effectors progressing through a linear differentiation pathway are two of several proposed models [reviewed in [37].”
New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza
Devarajan, P., Bautista, B., Vong, A. M., McKinstry, K. K., Strutt, T. M., & Swain, S. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00136 · Cited by 44
Effector and Regulatory T Cells Roll at High Shear Stress by Inducible Tether and Sling Formation
Abadier, M., Pramod, A. B., McArdle, S., Márki, A., Fan, Z., Gutierrez, E., Groisman, A., & Ley, K. F. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.099 · Cited by 45
A Novel Role of IL-15 in Early Activation of Memory CD8+ CTL after Reinfection
Yajima, T., Nishimura, H., Sad, S., Shen, H., Kuwano, H., & Yoshikai, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3590 · Cited by 41
Shanker, A., Buferne, M., & Schmitt‐Verhulst, A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03150.x · Cited by 40
The Dissection of CD8 T Cells During Liver-Stage Infection
Krzych, U., & Schwenk, R. (2005) · Springer eBooks · doi:10.1007/3-540-29967-x_1 · Cited by 43
“T cells [47].”
Shaulov, A., & Murali‐Krishna, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.1131 · Cited by 42
“T he generation of immunological memory is the end result of a productive, adaptive immune response and is the ultimate goal of vaccination (1, 2).”
BackgroundImmune Traffic: A Functional Overview
Beilhack, A., & Rockson, S. G. (2003) · Lymphatic Research and Biology · doi:10.1089/153968503768330256 · Cited by 42
“…2 to more than 24 h of TCR stimulation by antigen-presenting cells to reach commitment, while memory/effector T cells respond within 0.5– 2 h. 6,17 Trafficking of effector and memory cells Activation of naive lymphocytes after the encounter within antigen in the lymphoid environment leads to…”
InfluentialDermaVir, a novel HIV immunisation technology
Lori, F., Trocio, J. N., Bakare, N., KELLY, L., & Lisziewicz, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.004 · Cited by 42
Epigenetic regulation of T cell adaptive immunity
Frias, A. B., Boi, S. K., Lan, X., & Youngblood, B. (2021) · Immunological Reviews · doi:10.1111/imr.12943 · Cited by 49
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions
Weng, N. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101810 · Cited by 51
Miles, D. J. C., van der Sande, M. A. B., Jeffries, D. J., Kaye, S., Ojuola, O. O., Sanneh, M., Cox, M., Palmero, M. S., Touray, E. S., Waight, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002905 · Cited by 46
Histone Methyltransferase and Histone Methylation in Inflammatory T-Cell Responses
He, S., Tong, Q., Bishop, D. K., & Zhang, Y. (2013) · Immunotherapy · doi:10.2217/imt.13.101 · Cited by 41
Induction of T-cell memory by a dendritic cell vaccine: a computational model
Pappalardo, F., Pennisi, M. A., Ricupito, A., Topputo, F., & Bellone, M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu059 · Cited by 39
“However, what affects the longevity of memory T cells is not full understood, and much controversy exists regarding the role of antigens in this process (Zinkernagel, 2002; Sprent and Surh, 2011; Kaech et al., 2002).”
BackgroundHan, L., Xue, J., Wang, L., Peng, K., Zhang, Z., Gong, T., & Sun, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.007 · Cited by 41
Liu, S., Riley, J. P., Rosenberg, S. A., & Parkhurst, M. R. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000190168.53793.6b · Cited by 44
“In general, the phenotypic attributes of the peptide-specific cells were those associated with effector cells, most notably in the low levels of CD62L.(28) Cells grown in IL-7 alone usually had higher levels of this marker, consistent with the observed low levels of expansion.”
BackgroundObliterative bronchiolitis or chronic lung allograft rejection: A basic science review
Neuringer, I. P., Chalermskulrat, W., & Aris, R. M. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.01.009 · Cited by 41
No life without death—apoptosis as prerequisite for T cell activation
Winau, F., Hegasy, G. A., Kaufmann, S. H. E., & Schaible, U. E. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2940-6 · Cited by 47
Liu, Y., Peng, Y., Mi, M., Guevara-Patino, J. A., Munn, D. H., Fu, N., & He, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900008 · Cited by 45
“Following T cell expansion after immunization or microbial infection, there is a dramatic contraction phase in which 90 – 95% of CD8 T cells die, leaving 5–10% of activated CD8 T cells to become memory T cells (34).”
BackgroundSurvival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2
Engedal, N., Ertesvag, A., & Blomhoff, H. K. (2004) · International Immunology · doi:10.1093/intimm/dxh048 · Cited by 41
Origin of CD8+ effector and memory T cell subsets.
Stemberger, C., Neuenhahn, M., Buchholz, V. R., & Busch, D. H. (2007) · PubMed · Cited by 61
Amara, R. R., Ibegbu, C., Villinger, F. J., Montefiori, D. C., Sharma, S., Nigam, P., Xu, Y., McClure, H. M., & Robinson, H. L. (2005) · Virology · doi:10.1016/j.virol.2005.08.027 · Cited by 41
“Memory CD8 T cells with good functional characteristics possess high proliferative capacity to recall antigens (Kaech et al., 2002) and express high levels of the anti-apoptotic protein Bcl-2 (Grayson et al.”
Schmidt, F., Fields, H. F., Purwanti, Y. I., Milojkovic, A., Salim, S., Wu, K. X., Simoni, Y., Vitiello, A., MacLeod, D. T., Nardin, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113250 · Cited by 38
CARs: Beyond T Cells and T Cell-Derived Signaling Domains
Sievers, N. M., Dörrie, J., & Schaft, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103525 · Cited by 41
CD8 and B cell memory: same strategy, same signals
Tanchot, C., & Rocha, B. (2003) · Nature Immunology · doi:10.1038/ni0503-431 · Cited by 40
Adotévi, O., Mollier, K., Neuveut, C., Dosset, M., Ravel, P., Fridman, W. H., Tartour, É., Charneau, P., Wain–Hobson, S., & Langlade‐Demoyen, P. (2010) · Blood · doi:10.1182/blood-2009-11-253641 · Cited by 45
Ramaswamy, M., Cruz, A. C., Cleland, S. Y., Deng, M., Price, S. M., Rao, V. K., & Siegel, R. M. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.155 · Cited by 44
“T cells previously exposed to antigen acquire phenotypic and functional characteristics of memory T cells, including the ability to self-renew more efficiently and respond to antigen with minimal co-stimulation.(7) These properties are important for maintaining immunity to pathogens but may also allow the perpetuation…”
Stark, F. C., Sad, S., & Krishnan, L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3160 · Cited by 43
Li, S., Guo, Z., Zeng, G., Zhang, Y., Xue, W., & Liu, Z. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00370 · Cited by 40
Truckenmiller, M. E., Bonneau, R. H., & Norbury, C. C. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.01.002 · Cited by 45
Immunology and Immunotherapy in Neurosurgical Disease
Prins, R. M., & Liau, L. M. (2003) · Neurosurgery · doi:10.1227/01.neu.0000068865.34216.3a · Cited by 41
Brummelman, J., Helm, K., Hamstra, H.-J., van der Ley, P., Boog, C. J. P., Han, W. G. H., & van Els, C. A. C. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.063 · Cited by 39
Ravindran, R., Maji, M., & Ali, N. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2002494 · Cited by 39
Strategies and Implications for Prime-Boost Vaccination to Generate Memory CD8 T Cells
Nolz, J. C., & Harty, J. T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_7 · Cited by 38
The role of major immune cells in myocardial infarction
Feng, Q., Li, Q., Zhou, H., Sun, L., Lin, C., Ye, J., Wang, D., & Guo, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1084460 · Cited by 52
CMV‐specific central memory T cells reside in bone marrow
Letsch, A., Knoedler, M., Na, I., Kern, F., Asemissen, A., Keilholz, U., Loesch, M., Thiel, E., Volk, H., & Scheibenbogen, C. (2007) · European Journal of Immunology · doi:10.1002/eji.200636930 · Cited by 38
Lim, S., Meyer, M., Kjonaas, R. A., & Ghosh, S. K. (2007) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-5-3 · Cited by 39
“In many instances, specific antigen-adjuvant combinations have been shown to promote antigen-specific production of Th1 type cytokines of (IFN-γ, IL-2) and cytotoxic T-cell responses [36-38].”
Russell, M. S., Iskandar, M., Mykytczuk, O., Nash, J. H. E., Krishnan, L., & Sad, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.211 · Cited by 40
“Although higher doses of pathogens induce quantitatively more numbers of memory CD8 T cells, the slope of the CD8 T cell differentiation curve (expansion and contraction) remains identical in case of infection with the low or high dose of the pathogen (1).”
BackgroundMultiparameter precursor analysis of T-cell responses to antigen
Bercovici, N., Givan, A. L., Waugh, M., Fisher, J. L., Vernel-Pauillac, F., Ernstoff, M. S., Abastado, J., & Wallace, P. K. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00059-0 · Cited by 39
Agallou, M., Margaroni, M., Tsanaktsidou, E., Badounas, F., Kammona, O., Kiparissides, C. A., & Karagouni, E. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.006 · Cited by 41
Zeng, Z., Kong, X., Li, F., Wei, H., Sun, R., & Tian, Z. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203449 · Cited by 41
Regulation of effector and memory CD8+ T cell function by inflammatory cytokines
Valbon, S. F., Condotta, S. A., & Richer, M. J. (2015) · Cytokine · doi:10.1016/j.cyto.2015.11.013 · Cited by 47
Natural killer cell memory in context
Holmes, T. D., & Bryceson, Y. T. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.05.008 · Cited by 45
Zhang, Y., Cao, Y. Q., Sun, X., Feng, Y., Du, Y., Liu, F., Yu, C., & Jin, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.027 · Cited by 39
Bevington, S. L., Cauchy, P., Withers, D. R., Lane, P. J. L., & Cockerill, P. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00204 · Cited by 45
Haddadi, S., Thanthrige-Don, N., Afkhami, S., Khera, A., Jeyanathan, M., & Xing, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-09909-4 · Cited by 43
Lam, J. H., Chua, Y. L., Lee, P. X., Gómez, J. M. M., Ooi, E. E., & Alonso, S. (2017) · JCI Insight · doi:10.1172/jci.insight.94500 · Cited by 39
Clambey, E. T., White, J., Kappler, J. W., & Marrack, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805465105 · Cited by 38
“After initial exposure, naı̈ve CD8 T cells can differentiate into CD8 memory T cells, which can provide enhanced immunological protection on reexposure to that same pathogen (1).”
BackgroundHosking, M., Flynn, C. T., & Whitton, J. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400348 · Cited by 40
Alam, R., & Gorska, M. M. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.121 · Cited by 41
Hamilton, S. E., Porter, B. B., Messingham, K. N., Badovinac, V. P., & Harty, J. T. (2004) · Nature Immunology · doi:10.1038/ni1026 · Cited by 38
Role of peripheral immune cells in spinal cord injury
Li, C., Xiong, W., Wan, B., Kong, G., Wang, S., Wang, Y., & Fan, J. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04644-0 · Cited by 41
“Immune responses commence when naive T cells encounter antigens and costimulatory ligands presented by dendritic cells (DC) [56].”
Recent progress in cancer vaccines and nanovaccines
Poudel, K., Vithiananthan, T., Kim, J. O., & Tsao, H. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122856 · Cited by 43
Niu, H., Peng, J., Bai, C., Liu, X., Hu, L., Luo, Y., Wang, B., Zhang, Y., Chen, J., Yu, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130641 · Cited by 37
“Therefore, novel vaccines and vaccine strategy should aim at inducing long-lasting T cell responses [7].”
BackgroundKenna, T., Waldie, T., McNally, A., Thomson, M., Yagita∥, H., Thomas, R., & Steptoe, R. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900032 · Cited by 37
“In a primary immune response, the bulk of the clonally expanded T cells, primarily short-lived effector T cells, die (1, 2); however, a small proportion (5–10%) survives to generate memory cells (2).”
BackgroundLi, H., Liu, J., Carville, A., Mansfield, K. G., Lynch, D. M., & Barouch, D. H. (2011) · Journal of Virology · doi:10.1128/jvi.05346-11 · Cited by 37
“Effector responses may prove particularly important because of their ability to respond rapidly to incoming pathogens (17, 39, 40).”
BackgroundSteers, N. J., Peachman, K. K., McClain, S., Alving, C. R., & Rao, M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.105 · Cited by 37
Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major
Toribio‐Fernández, R., Zorita, V., Rocha‐Perugini, V., Iborra, S., del Hoyo, G. M., Chèvre, R., Dorado, B., Sancho, D., Sánchez‐Madrid, F., Andrés, V., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0007-6 · Cited by 37
Hao, X., Li, S., Li, J., Yang, Y., Qin, A., & Shang, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645426 · Cited by 37
D’Cruz, L. M., Lind, K. C., Wu, B. B., Fujimoto, J., & Goldrath, A. W. (2012) · European Journal of Immunology · doi:10.1002/eji.201242497 · Cited by 40
Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses
Doll, K. L., Pewe, L. L., Kurup, S. P., & Harty, J. T. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600155 · Cited by 44
Beck, B. R., Lee, S. H., Kim, D., Park, J. H., Lee, H. K., Kwon, S.-S., Lee, K. H., Lee, J. I., & Song, S. K. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.07.004 · Cited by 38
Pott, G. B., Palmer, B. E., Sullivan, A. K., Silviera, L., Maier, L. A., Newman, L. S., Kotzin, B. L., & Fontenot, A. P. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.019 · Cited by 37
Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers
Schott, M. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01133 · Cited by 39
Gangadhara, S., Husain, S., Nayak, B. P., & Jabbar, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2496 · Cited by 37
“Repeated immunizations could negatively impact on the outcome of the memory immune response (57).”
BackgroundAn In Vivo Cytotoxicity Threshold for Influenza A Virus-Specific Effector and Memory CD8+ T Cells
Stambas, J., Doherty, P. C., & Turner, S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1285 · Cited by 39
“Following TCR engagement and activation of the signaling cascade, virus-specific CD8 CTLs undergo a program of proliferation and differentiation as they acquire various effector functions (2, 3).”
BackgroundAdetifa, I., Ota, M. O. C., Walther, B., Hammond, A. S., Lugos, M. D., Jeffries, D. J., Donkor, S. A., Adegbola, R. A., & Hill, P. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012502 · Cited by 36
“tuberculosis.[5,6,31,32] Therefore it is not surprising that we found significant qualitative and quantitative test reversion with effective therapy.”
BackgroundCCR7+ Central and CCR7− Effector Memory CD4+ T Cells in Human Cutaneous Leishmaniasis
Valian, H. K., Rostami, M. N., Tasbihi, M., Mohammadi, A. M., Eskandari, S. E., Sarrafnejad, A., & Khamesipour, A. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9788-7 · Cited by 37
Mechanisms behind Functional Avidity Maturation in T Cells
von Essen, M. R., Kongsbak‐Wismann, M., & Geisler, C. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/163453 · Cited by 36
“During an immune response antigen-primed B-cells increase their antigen responsiveness by affinity maturation mediated by somatic hypermutation of the genes encoding the antigen-specific B-cell receptor (BCR) and by selection of higher-affinity B cell clones.”
BackgroundInfluentialCasas, I., Latorre, I., Esteve, M. G., Manzano, J. R., Rodriguez, D., Prat, C., García-Olivé, I., Lacoma, A., Ausina, V., & Domínguez, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006686 · Cited by 36
“It is thought that central memory T cells, but not effector ones, may take several days (rather than hours) to produce effector cytokines [30,31].”
BackgroundYu, G., Li, Y., Cui, Z.-H., Morris, N. P., Weinberg, A. D., Fox, B. A., Urba, W. J., Wang, L., & Hu, H. (2016) · Scientific Reports · doi:10.1038/srep37558 · Cited by 39
STAT5B: A Differential Regulator of the Life and Death of CD4+ Effector Memory T Cells
Majri-Morrison, S. S., Fritz, J. M., Villarino, A. V., Zheng, L., Kanellopoulou, C., Chaigne-Delalande, B., Grönholm, J., Niemela, J. E., Afzali, B., Biancalana, M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701133 · Cited by 39
“the death process allows for the survival of long-lived, self-renewing memory T cells that are capable of mounting a rapid response upon rechallenge (20).”
BackgroundSong, Y., Wang, Y., Wang, S., Cheng, Y. S., Lu, Q., Yang, L., Tan, F., & Li, N. (2019) · Nano Research · doi:10.1007/s12274-019-2341-8 · Cited by 36
Jiang, D., Sun, Y., Cheng, L., Zhang, G.-F., Dong, C., Jin, B., Song, C., Ma, Y., Zhang, F., & Yang, K. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.007 · Cited by 36
T cell responses to control fungal infection in an immunological memory lens
Sharma, J., Mudalagiriyappa, S., & Nanjappa, S. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905867 · Cited by 42
CD8 T Cells Can Reject Major Histocompatibility Complex Class I‐Deficient Skin Allografts
He, C.-S., & Heeger, P. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00416.x · Cited by 43
“The primed CD8+ effector T cell subsequently acquires the ability to circulate through the periphery where a second encounter with its specific ligand triggers effector functions resulting in local injury and/or cell destruction (6,7).”
BackgroundAn in-host model of acute infection: Measles as a case study
Heffernan, J. M., & Keeling, M. J. (2007) · Theoretical Population Biology · doi:10.1016/j.tpb.2007.10.003 · Cited by 39
“Activated CD8 T-cells proliferate at least 7 times with stimulation of antigen (Kaech and Ahmed, 2001; Kaech et al., 2002).”
BackgroundNemoto, Y., Kanai∥, T., Kameyama, K., Shinohara, T., Sakamoto, N., Totsuka, T., Okamoto, R., Tsuchiya, K., Nakamura, T., Sudo, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803684 · Cited by 36
“For example, in the lymphocytic choriomeningitis virus model of acute viral infection, lymphocytes differentiate into CD8 memory T cells for the first time after the virus has been eliminated (20, 21).”
Metadata
- Authors
- Kaech, S. M., Wherry, E. J., & Ahmed, R.
- Affiliations
- Emory University (US)
- Corresponding author
- Ahmed, Rafi
- Venue
- Nature Reviews Immunology
- Published
- 2002-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 251-262
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2170904230
- Cited by
- 1,865
- References
- 137
- Citations by year
- 2026: 54 · 2025: 91 · 2024: 94 · 2023: 96 · 2022: 101 · 2021: 73 · 2020: 50 · 2019: 48 · 2018: 45 · 2017: 61 · 2016: 62 · 2015: 62 · 2014: 81 · 2013: 65 · 2012: 64
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- effector T cells, memory T cells, T cell differentiation, CD4+ T cells, CD8+ T cells, T cell proliferation, antigen stimulation, vaccine design
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunologic Memory, T-Lymphocytes, Vaccines, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.